Log In
Print
BCIQ
Print
Print this Print this
 

ruboxistaurin (Arxxant)

Also known as: LY333531

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionSynthetic protein kinase C (PKC) beta inhibitor
Molecular Target Protein kinase C (PKC) beta (PRKCB)
Mechanism of ActionProtein kinase C (PKC) beta inhibitor
Latest Stage of DevelopmentRegistration
IndicationDiabetic retinopathy
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today